PHOTO
Abu Dhabi, UAE: The National Health Insurance Company – Daman announced that over 60% of participants in its diabetes management programme have maintained or reduced their risks to develop complications over a period of 12 months with 89% following the programme’s coaches guidance to improve their quality of life.
The UAE’s leading health insurer revealed these findings following case reviews of over 4,100 enrolled members, which found that 63% of members enrolled in the programme have reduced or maintained their glycated haemoglobin (Hb1Ac) levels of which 46%, around 2,000 members, have managed to reduce their levels by over 1.6%. Such a reduction is known to decrease the risks associated with the disease’s complications and improve the patient’s quality of life.
The health insurer noted this as a clinically meaningful outcome considering that the normal rate of Hb1Ac is 5.6% and a diagnosis of diabetes is made when it exceeds 6.5%. Studies show that those with type 2 diabetes who reduce their haemoglobin level by 1% are 19% less likely to suffer cataracts, 16% less likely to suffer heart failure, and 43% less likely to suffer amputation or death due to peripheral vascular disease.[1]
Daman has been providing the diabetes management programme over the past ten years, with over 17,000 members benefitting through Daman’s programme. The initiative provides diabetic members of the insurer with nutritional and exercise advice, as well as offering personal and educational support on applying adjustments to daily routines to cope with the condition and improve a members’ long-term quality of life.
Speaking on the success of the programme, Hamad Al Mehyas, Chief Executive Officer of the National Health Insurance Company – Daman, said: “Studies indicate that over 17.3% of the UAE population, aged 20 – 79, live with type 2 diabetes.[2] Nonetheless, with more advancements made in diabetes research and treatment, it is increasingly becoming an easily manageable condition for many patients. As a result, the daily impact of diabetes on patients’ quality of life continues to diminish.
“When we launched the programme over a decade ago, it was the first of its kind in the region, not just among health insurers, but in general as a novel concept. We are proud of what we have achieved so far, and are excited with what we can achieve in the next decade and beyond, as we continue to deliver on our commitment to support our members and the wider UAE community.”
The measure of glycated haemoglobin (HbA1c) is a globally recognised metric for assessing the average level of an individual’s blood sugar over a long-term period. Normal levels of HbA1c in blood sugar are below 6%, while levels of HbA1c in diabetic patients is at 6.5% or over. Studies have demonstrated that a reduction of 1% of HbA1c levels for those with either type 1 or type 2 diabetes cuts the risk of microvascular complications by 25%.[3]
Daman offers a range of disease management programmes, helping to shape a healthier and more activity community in the UAE. Additional programmes include management of asthma and maternity.
[1] Diabetes UK
[2] IDF Diabetes Atlas
[3] Diabetes UK
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
